These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2373673)

  • 1. Ofloxacin therapy of Mycobacterium fortuitum infection: further experience.
    Yew WW; Kwan SY; Ma WK; Lui KS; Suen HC
    J Antimicrob Chemother; 1990 May; 25(5):880-1. PubMed ID: 2373673
    [No Abstract]   [Full Text] [Related]  

  • 2. Single daily-dose ofloxacin monotherapy for Mycobacterium fortuitum sternotomy infection.
    Yew WW; Kwan SY; Ma WK; Khin MA; Mok CK
    Chest; 1989 Nov; 96(5):1150-2. PubMed ID: 2805845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of ofloxacin and amikacin in the treatment of sternotomy wound infection.
    Yew WW; Kwan SY; Ma WK; Aung-khin M; Mok CK
    Chest; 1989 May; 95(5):1051-5. PubMed ID: 2707062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial activity of ofloxacin and other agents against mycobacterial isolates from postoperative sternotomy wounds.
    Yew WW; Kwan SY; Ma WK; Lui KS; Aung MK
    Clin Ther; 1989; 11(6):775-85. PubMed ID: 2611821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary Mycobacterium fortuitum infection.
    Oren B; Raz R; Hass H
    Infection; 1990; 18(2):105-6. PubMed ID: 2332244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ofloxacin and imipenem in the treatment of Mycobacterium fortuitum and Mycobacterium chelonae lung infections.
    Yew WW; Kwan SY; Wong PC; Lee J
    Tubercle; 1990 Jun; 71(2):131-3. PubMed ID: 2219463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei.
    Dalovisio JR; Pankey GA; Wallace RJ; Jones DB
    Rev Infect Dis; 1981; 3(5):1068-74. PubMed ID: 7339806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual clinical presentation of Mycobacterium fortuitum infection in an immunocompetent woman.
    Serra C; Loi G; Saddi B; Pautasso M; Manzin A
    J Clin Microbiol; 2007 May; 45(5):1663-5. PubMed ID: 17360837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium fortuitum infections of the mediastinum.
    Sethi GK; Simons WJ; Scott SM
    J Cardiovasc Surg (Torino); 1985; 26(3):307-9. PubMed ID: 3997975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ofloxacin in the treatment of pulmonary changes caused by Mycobacterium avium and Mycobacterium xenopii].
    Zwoliński J; Gałazka J
    Pneumonol Alergol Pol; 1992; 60(5-6):70-3. PubMed ID: 1290992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pacemaker infections due to rapidly growing mycobacteria: further experience.
    Tam WO; Yew WW; Yam WC; Yuen KY; Wong PC; Tse TF
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):118. PubMed ID: 17217143
    [No Abstract]   [Full Text] [Related]  

  • 12. Post-Facelift Infection Due to Mycobacterium Fortuitum: A Case Report.
    Chazan B; Shoufani A; Strauss M; Yanovskay A
    Isr Med Assoc J; 2018 Aug; 20(8):524-525. PubMed ID: 30084582
    [No Abstract]   [Full Text] [Related]  

  • 13. Mycobacterium fortuitum lung abscess: resolution with prolonged trimethoprim/sulfamethoxazole therapy.
    Pacht ER
    Am Rev Respir Dis; 1990 Jun; 141(6):1599-601. PubMed ID: 2350102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium fortuitum infection in prosthetic breast implants.
    Haiavy J; Tobin H
    Plast Reconstr Surg; 2002 May; 109(6):2124-8. PubMed ID: 11994623
    [No Abstract]   [Full Text] [Related]  

  • 15. Mycobacterium fortuitum infection of the scalp after a skin graft.
    Smith BD; Liras IN; De Cicco IA; Aisenberg GM
    BMJ Case Rep; 2016 Oct; 2016():. PubMed ID: 27797799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical case and a review of Mycobacterium fortuitum infections direct diagnosis approach and treatment in a patient with leg fractures.
    Wang J; Huang J; Peng S; Li L; Zhong K; Chen T
    J Infect Dev Ctries; 2022 Oct; 16(10):1650-1654. PubMed ID: 36332221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ofloxacin combined with Lactobacillus casei against Mycobacterium fortuitum infection induced in mice.
    Tomioka H; Sato K; Saito H
    Antimicrob Agents Chemother; 1990 Apr; 34(4):632-6. PubMed ID: 2344170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nontuberculous mycobacteriosis. Report of 2 cases of infection by mycobacteria of the MAI (atypical Mycobacteria) group and its treatment with cephalosporins].
    Marticorena BE; Micheli ZA; Armella MA; Kevorkof GV; Nigro DR
    Rev Fac Cien Med Univ Nac Cordoba; 1987; 45(1):28, 31-2. PubMed ID: 3449918
    [No Abstract]   [Full Text] [Related]  

  • 19. Activities of cefoxitin and cefotetan against Mycobacterium fortuitum infections in mice.
    Saito H; Sato K; Jin BW
    Antimicrob Agents Chemother; 1984 Aug; 26(2):270-1. PubMed ID: 6592999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium fortuitum infection in a renal transplant recipient.
    Ram R; Swarnalatha G; Naidu GD; Pai BH; Dakshinamurty KV
    Int Urol Nephrol; 2013 Apr; 45(2):595-6. PubMed ID: 22453794
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.